Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RDNT
RDNT logo

RDNT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy RadNet Inc (RDNT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
58.190
1 Day change
1.20%
52 Week Range
85.840
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

RadNet Inc (RDNT) is not a strong buy for a beginner, long-term investor at this moment. While hedge funds are increasing their positions and the stock shows potential for modest short-term gains, the company's financial performance is weak, with declining net income, EPS, and gross margin. Additionally, there are no significant technical signals or news catalysts to support a strong buy decision. A hold is recommended until stronger financial performance or catalysts emerge.

Technical Analysis

The MACD histogram is 0.47, above 0, and positively contracting, indicating mild bullish momentum. RSI is neutral at 38.056, and moving averages are converging, suggesting no clear trend. The stock is trading near support levels (S1: 55.168), with resistance at R1: 62.029. Overall, the technical indicators do not strongly favor a buy.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment in the options market. However, implied volatility is high (IV Percentile: 96.02), suggesting elevated risk.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
6

Positive Catalysts

  • Hedge funds have increased their buying by 139.49% over the last quarter, indicating institutional interest. The stock has an 80% chance of gaining 3.34% in the next week and 3.37% in the next month.

Neutral/Negative Catalysts

  • The company's financial performance in Q4 2025 shows a significant decline in net income (-111.17% YoY), EPS (-114.29% YoY), and gross margin (-54.47% YoY). There are no recent news catalysts or insider trading trends to support a buy decision.

Financial Performance

In Q4 2025, revenue increased by 14.80% YoY to $547.71M. However, net income dropped to -$597,000, EPS fell to -0.01, and gross margin decreased to 4.79%. These declines indicate deteriorating profitability despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for RDNT.

Wall Street analysts forecast RDNT stock price to rise
6 Analyst Rating
Wall Street analysts forecast RDNT stock price to rise
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 57.500
sliders
Low
86
Averages
90.17
High
95
Current: 57.500
sliders
Low
86
Averages
90.17
High
95
B. Riley
Buy
downgrade
$87 -> $83
AI Analysis
2026-05-01
Reason
B. Riley
Price Target
$87 -> $83
AI Analysis
2026-05-01
downgrade
Buy
Reason
B. Riley lowered the firm's price target on RadNet to $83 from $87 and keeps a Buy rating on the shares. The Q1 reports across the radiotherapeutics and imaging agents point to a multi-indication PET volume growth, the analyst tells investors in a research note.
KeyBanc
NULL -> Overweight
initiated
$92
2026-01-09
Reason
KeyBanc
Price Target
$92
2026-01-09
initiated
NULL -> Overweight
Reason
KeyBanc last night initiated coverage of RadNet with an Overweight rating and $92 price target. The firm believes outpatient diagnostic imaging is an attractive subsector, supported by "powerful" growth drivers including hospital-to-outpatient shift and growing demand for advanced imaging. RadNet's targets for 2025 through 2028 "seem very reasonable," especially in the context of better Medicare rates, potential for capital deployment upside, and ramping AI benefits, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RDNT
Unlock Now

People Also Watch